Rheumatoid Arthritis Treatment


rheumatoid arthritis treatmentRheumatoid Arthritis Treatment

Why should you learn to live with it, when there is an alternative? Welcome to the functional medicine approach to rheumatoid arthritis treatment.

Most cases of Rheumatoid Arthritis usually respond well to Natural Medicine and lifestyle changes. Our Rheumatoid Arthritis treatment has seen many clinical successes.

Conventional pharmaceutical drugs and their side effects:

Modern treatments include symptomatic treatment for arthritis pain and inflammation, intervention with strong toxic drugs and surgical treatment of joint damage. Non-steroidal anti-inflammatory drugs (NSAIDs) are the mainstay of the conventional treatment for arthritis pain. These drugs are COX-inhibitors, which often cause the side effects of stomach erosion and increased bleeding tendency, sometimes leading to death by gastrointestinal haemorrhage.

It’s not unusual to hear patients complaining of side-effects and not enough pain relief. We have already witnessed the 2004 withdrawal of the drug, Vioxx, one of the main COX-2 inhibitors, due to increased cardiac deaths. Recent studies have raised serious concerns regarding the long-term safety of all non-steroidal anti-inflammatory drugs (NSAIDs). Some of the most commonly used NSAIDs are in fact more likely to cause heart attacks than Vioxx.

In 2005, a study of more than 9000 people aged 25 to 100, who had suffered their first ever heart attack, was published in the British Medical Journal (BMJ). A significantly increased risk of heart attack was observed for Diclofenac (55% increase), Ibuprofen (24% increase), Rofecoxib (32% increase) and Naproxen (27% increase). The authors concluded that their study suggested that enough concerns may exist to warrant a reconsideration of the safety of all NSAIDs.

They also concluded that as serious adverse events are associated with non-steroidal anti-inflammatory drugs, only their limited use can be recommended. Clearly the message from the current research is that non-steroidal anti-inflammatory drugs should not be the first option for the treatment for arthritis pain.

Natural Medicine – Rheumatoid Arthritis Treatment:

We do not give one-size-fits-all symptomatic treatment. Instead, we diagnose the underlying issues that are the drivers of this inflammatory condition and a treatment plan is then formulated, based on the test results. This provides a treatment specifically for each patient, meeting their unique needs.

Most cases of rheumatoid arthritis usually respond well to Natural Medicine and lifestyle changes. It provides gentle, safe and effective treatment, avoiding the unwanted side effects of pharmaceutical drugs.

There are no ‘standard prescriptions’ for particular conditions. Instead, tailor-made prescriptions are formulated to meet an individual patient’s unique needs. Natural Medicines are dispensed from our own dispensary, using medicine authorised by the Department of Health’s Medicines and Healthcare products Regulatory Agency.

The clinical efficacy of Natural Medicine in pain management has already been demonstrated in clinical trials. It has a superior safety and efficacy profile compared to NSAIDs. Professor Reinhard Saller, a rheumatologist based in Zurich, observed that the excellent results he encountered in his own practice attested to its anti-inflammatory and analgesic (painkiller) potential.

We also address the gut issues, which are often associated with this condition.

References

The mechanism of action of tofacitinib – an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M, Zwillich S.Clin Exp Rheumatol. 2016 Mar-Apr;34(2):318-28. Epub 2016 Mar 10.PMID: 26966791 Review.

Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds. Migita K, Izumi Y, Torigoshi T, Satomura K, Izumi M, Nishino Y, Jiuchi Y, Nakamura M, Kozuru H, Nonaka F, Eguchi K, Kawakami A, Motokawa S.Clin Exp Immunol. 2013 Dec;174(3):356-63. doi: 10.1111/cei.12190.PMID: 23968543

Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Yarilina A, Xu K, Chan C, Ivashkiv LB.Arthritis Rheum. 2012 Dec;64(12):3856-66. doi: 10.1002/art.37691.PMID: 22941906

Novel therapeutic targets in rheumatoid arthritis. Koenders MI, van den Berg WB.Trends Pharmacol Sci. 2015 Apr;36(4):189-95. doi: 10.1016/j.tips.2015.02.001. Epub 2015 Feb 27.PMID: 25732812 Review.

Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. Benveniste EN, Liu Y, McFarland BC, Qin H.J Interferon Cytokine Res. 2014 Aug;34(8):577-88. doi: 10.1089/jir.2014.0012.PMID: 25084174


If you would like to book an appointment

Contact Deborah’s Medical Secretary for an appointment